The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
TINF2, a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenita
Open accessAbstract
Patients with dyskeratosis congenita (DC), a heterogeneous inherited bone marrow failure syndrome, have abnormalities in telomere biology, including very short telomeres and germline mutations in DKC1, TERC, TERT, or NOP10, but approximately 60% of DC patients lack an identifiable mutation. With the very short telomere phenotype and a highly penetrant, rare disease model, a linkage scan was performed on a family with autosomal-dominant DC and no mutations in DKCI, TERC, or TERT. Evidence favoring linkage was found at 2p24 and 14q11.2, and this led to the identification of TINF2 (14q11.2) mutations, K280E, in the proband and her five affected relatives and TINF2 R282H in three additional unrelated DC probands, including one with Revesz syndrome; a fifth DC proband had a R282S mutation. TINF2 mutations were not present in unaffected relatives, DC probands with mutations in DKC1, TERC, or TERT or 298 control subjects. We demonstrate that a fifth gene, TINF2, is mutated in classical DC and, for the first time, in Revesz syndrome. This represents the first shelterin complex mutation linked to human disease and confirms the role of very short telomeres as a diagnostic test for DC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Shelterin mutations have been found in some cases of aplastic anemia and dyskeratosis congenita (Savage et al., 2008; Walne et al., 2008; Zhong et al., 2011).”
From The Hallmarks of Aging (2013) · cites this paper as Savage et al., 2008
In the citing paper
“Autosomal dominant forms are caused by mutations in TERT, TERC or the telomere binding protein TRF1-interacting nuclear factor 2 (156-159).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [156]
In the citing paper
“Eight mutant genes have been identified in dyskeratosis congenita9,38,39,60–64, and all of them encode telomerase or telomere protein components (summarized in Table 1).”
From The telomere syndromes (2012) · cites this paper as [62]
Citations
Cites
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,601
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
VISTA: computational tools for comparative genomics
Frazer, K. A., Pachter, L. S., Poliakov, A., Rubin, E. M., & Dubchak, I. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh458 · Cited by 2,821
ESEfinder: a web resource to identify exonic splicing enhancers
Cartegni, L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg616 · Cited by 1,593
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Predictive Identification of Exonic Splicing Enhancers in Human Genes
Fairbrother, W. G., Yeh, R., Sharp, P. A., & Burge, C. B. (2002) · Science · doi:10.1126/science.1073774 · Cited by 1,020
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723
Self-citationTelomerase in the human organism
Collins, K., & Mitchell, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205083 · Cited by 616
Connecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561
Cited by
Sorted by citations
Items 101–200 of 412
Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood
Sasa, G., Ribes‐Zamora, A., Nelson, N., & Bertuch, A. A. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01658.x · Cited by 90
Short Telomeres in Key Tissues Initiate Local and Systemic Aging in Zebrafish
Carneiro, M. C., Henriques, C. M., Nabais, J., Ferreira, T., Carvalho, T., & Ferreira, M. G. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005798 · Cited by 87
Savage, S. A., & Dufour, C. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2017.04.004 · Cited by 88
Self-citationTRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells
Schneider, R. P., Garrobo, I., Foronda, M., Palacios, J., Marión, R. M., Flores, I., Ortega, S., & Blasco, M. A. (2013) · Nature Communications · doi:10.1038/ncomms2946 · Cited by 84
An Optimised Step-by-Step Protocol for Measuring Relative Telomere Length
Joglekar, M. V., Satoor, S. N., Wong, W. K. M., Cheng, F., Ronald, C. W., & Hardikar, A. A. (2020) · Methods and Protocols · doi:10.3390/mps3020027 · Cited by 78
Armstrong, C. A., & Tomita, K. (2017) · Open Biology · doi:10.1098/rsob.160338 · Cited by 83
Bessler, M., Wilson, D. B., & Mason, P. J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.019 · Cited by 83
Genomic Characterization of the Inherited Bone Marrow Failure Syndromes
Khincha, P. P., & Savage, S. A. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.09.002 · Cited by 79
Self-citationPhysical Activity and Telomere Biology: Exploring the Link with Aging-Related Disease Prevention
Ludlow, A. T., & Roth, S. M. (2011) · Journal of Aging Research · doi:10.4061/2011/790378 · Cited by 80
TRF2-Tethered TIN2 Can Mediate Telomere Protection by TPP1/POT1
Frescas, D., & de Lange, T. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01052-13 · Cited by 78
The role of telomere biology in bone marrow failure and other disorders
Savage, S. A., & Alter, B. P. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.002 · Cited by 75
Self-citationHuman Telomeres and Telomere Biology Disorders
Savage, S. A. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00002-5 · Cited by 78
Self-citationMolecular basis of telomere dysfunction in human genetic diseases
Sarek, G., Marzec, P., Margalef, P., & Boulton, S. J. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3093 · Cited by 79
Calado, R. T. (2009) · Hematology · doi:10.1182/asheducation-2009.1.338 · Cited by 74
Many disease-associated variants of hTERT retain high telomerase enzymatic activity
Zaug, A. J., Crary, S. M., Fioravanti, M. J., Campbell, K. P., & Cech, T. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt653 · Cited by 73
Gu, P., & Chang, S. S. (2013) · Aging Cell · doi:10.1111/acel.12139 · Cited by 73
The biology and management of dyskeratosis congenita and related disorders of telomeres
Tummala, H., Walne, A. J., & Dokal, I. S. (2022) · Expert Review of Hematology · doi:10.1080/17474086.2022.2108784 · Cited by 71
Pereboom, T. C., van Weele, L. J., Bondt, A., & MacInnes, A. W. (2011) · Blood · doi:10.1182/blood-2011-04-351460 · Cited by 69
Dyskeratosis congenita: The first NIH clinical research workshop
Savage, S. A., Dokal, I. S., Armanios, M. Y., Aubert, G., Cowen, E. W., Domingo, D. L., Giri, N., Greene, M. H., Orchard, P. J., Tolar, J., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22061 · Cited by 69
Self-citationTrahan, C., Martel, C., & Dragon, F. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp551 · Cited by 73
Giri, N., Lee, R. L., Faro, A., Huddleston, C. B., White, F. V., Alter, B. P., & Savage, S. A. (2011) · BMC Blood Disorders · doi:10.1186/1471-2326-11-3 · Cited by 70
Self-citationTsangaris, E., Klaassen, R. J., Fernandez, C. V., Yanofsky, R., Shereck, E. B., Champagne, J., Silva, M., Lipton, J. H., Brossard, J., Michon, B., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2011.089821 · Cited by 68
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of TelomeresPreprint
Roake, C. M., & Artandi, S. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026088 · Cited by 70
Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita
Parry, E. M., Alder, J. K., Lee, S. S., Phillips, J. A., Loyd, J. E., Duggal, P., & Armanios, M. Y. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.085100 · Cited by 69
Inherited bone marrow failure syndromes in adolescents and young adults
Wilson, D. B., Link, D. C., Mason, P. J., & Bessler, M. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.915579 · Cited by 66
Telomere Biology and Telomere Diseases: Implications for Practice and Research
Young, N. S. (2010) · Hematology · doi:10.1182/asheducation-2010.1.30 · Cited by 66
Kallen, M. E., Dulau‐Florea, A., Wang, W., & Calvo, K. R. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.05.016 · Cited by 66
TIN2 Protein Dyskeratosis Congenita Missense Mutants Are Defective in Association with Telomerase
Yang, D., He, Q., Kim, H., Ma, W., & Songyang, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225870 · Cited by 66
The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres
Frank, A. K., Tran, D. C., Qu, R. W., Stohr, B. A., Segal, D. J., & Xu, L. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005410 · Cited by 67
Recognizing familial myeloid leukemia in adults
Nickels, E. M., Soodalter, J. A., Churpek, J. E., & Godley, L. A. (2013) · Therapeutic Advances in Hematology · doi:10.1177/2040620713487399 · Cited by 68
Venturi, G., & Montanaro, L. (2020) · Cells · doi:10.3390/cells9102300 · Cited by 62
The shelterin complex and hematopoiesis
Jones, M., Bisht, K. K., Savage, S. A., Nandakumar, J., Keegan, C. E., & Maillard, I. P. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84547 · Cited by 64
Self-citationAlder, J. K., Sutton, R. M., Iasella, C. J., Nouraie, M. S., Koshy, R., Hannan, S. J., Chan, E. G., Chen, X., Zhang, Y., Brown, M. J., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.11.008 · Cited by 60
Updated review of genetic reticulate pigmentary disorders
Zhang, J., Li, M., & Yao, Z. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15575 · Cited by 56
A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in micePreprint
Frescas, D., & de Lange, T. (2014) · Genes & Development · doi:10.1101/gad.233395.113 · Cited by 61
TIN2 Functions with TPP1/POT1 To Stimulate Telomerase Processivity
Pike, A. M., Strong, M. A., Ouyang, J. P. T., Connelly, C. J., & Greider, C. W. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00593-18 · Cited by 57
Telomere function and regulation from mouse models to human ageing and disease
Jones-Weinert, C. W., Mainz, L., & Karlseder, J. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00800-5 · Cited by 63
Pulmonary fibrosis in dyskeratosis congenita withTINF2gene mutation
Fukuhara, A., Tanino, Y., Ishii, T., Inokoshi, Y., Saito, K., Fukuhara, N., Sato, S., Saito, J., Ishida, T., Yamaguchi, H., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00149113 · Cited by 55
Tümpel, S., & Rudolph, K. L. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06547.x · Cited by 59
TINF2 is a haploinsufficient tumor suppressor that limits telomere length
Schmutz, I., Mensenkamp, A. R., Takai, K., Haadsma, M., Spruijt, L., de Voer, R. M., Choo, S.-A. S., Lorbeer, F. K., van Grinsven, E. J., Hockemeyer, D. F., et al. (2020) · eLife · doi:10.7554/elife.61235 · Cited by 56
Balogh, E., Chandler, J. C., Varga, M., Tahoun, M. M., Menyhárd, D. K., Schay, G., Goncalves, T., Hamar, R., Légrádi, R., Szekeres, Á., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002328117 · Cited by 53
Genetic Interstitial Lung Disease
Devine, M., & Garcia, C. K. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.11.001 · Cited by 55
Telomere Length Reprogramming in Embryos and Stem Cells
Kalmbach, K., Robinson, L. G., Wang, F., Liu, L., & Keefe, D. L. (2014) · BioMed Research International · doi:10.1155/2014/925121 · Cited by 51
Montanaro, L. (2010) · The Journal of Pathology · doi:10.1002/path.2777 · Cited by 51
Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita
Agarwal, S. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.04.003 · Cited by 51
Trahan, C., & Dragon, F. (2008) · RNA · doi:10.1261/rna.1354009 · Cited by 52
p16INK4a protects against dysfunctional telomere–induced ATR-dependent DNA damage responses
Wang, Y., Sharpless, N. E., & Chang, S. S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69574 · Cited by 49
Amir, M., Κhan, P., Queen, A., Dohare, R., Alajmi, M. F., Hussain, A., Islam, A., Ahmad, F., & Hassan, M. I. (2020) · Cells · doi:10.3390/cells9020359 · Cited by 53
Telomere Dysfunction, Chromosomal Instability and Cancer
Meena, J. K., Rudolph, K. L., & Güneş, Ç. (2015) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-20291-4_3 · Cited by 51
Lee, J. H., Jung, M.-S., Hong, J., Kim, M. K., & Chung, I. K. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky223 · Cited by 50
Heterogeneous telomere defects in patients with severe forms of dyskeratosis congenita
Touzot, F., Gaillard, L., Vasquez, N., Guen, T. L., Bertrand, Y., Bourhis, J., Leblanc, T. M., Fischer, A., Soulier, J., de Villartay, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.043 · Cited by 52
Zhang, Y., Morimoto, K., Danilova, N., Zhang, B., & Lin, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030188 · Cited by 46
Hepatic manifestations of telomere biology disorders
Patnaik, M. M., Kamath, P. S., & Simonetto, D. A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.006 · Cited by 45
Gu, B.-W., Fan, J., Bessler, M., & Mason, P. J. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00674.x · Cited by 45
Changes of telomere status with aging: An update
Ishikawa, N., Nakamura, K., Izumiyama‐Shimomura, N., Aida, J., Matsuda, Y., Arai, T., & Takubo, K. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12772 · Cited by 45
Fernandes, S. G., Dsouza, R., & Khattar, E. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103633 · Cited by 43
Lamm, N., Elly, O., Shponkin, R., Richler, C., Aker, M., & Tzfati, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005666 · Cited by 46
Genome stability from the perspective of telomere length
Lu, X., & Liu, L. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.10.013 · Cited by 44
Telomere biology and translational research
Mason, P. J., & Perdigones, N. (2013) · Translational research · doi:10.1016/j.trsl.2013.08.009 · Cited by 44
Clinical approach to marrow failure
Shimamura, A. (2009) · Hematology · doi:10.1182/asheducation-2009.1.329 · Cited by 41
The wide-ranging clinical implications of the Short Telomere Syndromes
Barbaro, P. M., Ziegler, D. S., & Reddel, R. R. (2016) · Internal Medicine Journal · doi:10.1111/imj.12868 · Cited by 40
Hills, M., & Lansdorp, P. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04565.x · Cited by 42
Self-citationTelomere-Regulating Genes and the Telomere Interactome in Familial Cancers
Robles‐Espinoza, C. D., Velasco‐Herrera, M. D. C., Hayward, N. K., & Adams, D. J. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0305 · Cited by 42
Monogenic mutations associated with IgA deficiency
Abolhassani, H., Aghamohammadi, A., & Hammarström, L. L. G. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1198696 · Cited by 40
Recent progress in dyskeratosis congenita
Nishio, N., & Kojima, S. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0695-5 · Cited by 40
Tripathi, E., & Smith, S. H. (2016) · The EMBO Journal · doi:10.15252/embj.201695135 · Cited by 41
Vulliamy, T., Beswick, R. W., Kirwan, M., Hossain, U., Walne, A. J., & Dokal, I. S. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01605.x · Cited by 40
Akbay, E. A., Peña, C. G., Ruder, D., Michel, J., Nakada, Y., Pathak, S., Multani, A. S., Chang, S. S., & Castrillón, D. H. (2012) · Oncogene · doi:10.1038/onc.2012.232 · Cited by 38
Patel, T., Vasan, R., Gupta, D., Patel, J., & Trivedi, M. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.8.3085 · Cited by 39
Bergstrand, S., Böhm, S., Malmgren, H., Norberg, A., Sundin, M., Nordgren, A., & Farnebo, M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2421-4 · Cited by 37
High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders
Norris, K., Walne, A. J., Ponsford, M., Cleal, K., Grimstead, J. W., Ellison, A., Alnajar, J., Dokal, I. S., Vulliamy, T., & Baird, D. M. (2021) · Human Genetics · doi:10.1007/s00439-021-02257-4 · Cited by 39
Dyskeratosis congenita and the DNA damage response
Kirwan, M., Beswick, R. W., Walne, A. J., Hossain, U., Casimir, C. M., Vulliamy, T., & Dokal, I. S. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08679.x · Cited by 37
Kirwan, M., Beswick, R. W., Vulliamy, T., Nathwani, A. C., Walne, A. J., Casimir, C. M., & Dokal, I. S. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07516.x · Cited by 39
Dey, A., & Chakrabarti, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020333 · Cited by 40
ERCC6L2‐associated inherited bone marrow failure syndrome
Shabanova, I., Cohen, E., Cada, M., Vincent, A., Cohn, R. D., & Dror, Y. (2018) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.388 · Cited by 36
Irvine, A. D., & Mellerio, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch15 · Cited by 35
Telomere length and cancer risk: finding Goldilocks
Savage, S. A. (2023) · Biogerontology · doi:10.1007/s10522-023-10080-9 · Cited by 38
Self-citationTelomerase and Telomeres in Endometrial Cancer
Alnafakh, R., Adishesh, M., Button, L., Saretzki, G. C., & Hapangama, D. K. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00344 · Cited by 35
TINF2 mutations in children with severe aplastic anemia
Du, H., Mason, P. J., Bessler, M., & Wilson, D. B. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21903 · Cited by 35
Understanding telomere diseases through analysis of patient-derived iPS cells
Batista, L. F. Z., & Artandi, S. E. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.07.006 · Cited by 35
Clinical Correlates and Treatment Outcomes for Patients With Short Telomere Syndromes
Mangaonkar, A. A., Ferrer, A., Vairo, F. P. E., Cousin, M. A., Kuisle, R. J., Klee, E. W., Kennedy, C. C., Peters, S. G., Scott, J. P., Utz, J. P., et al. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.05.015 · Cited by 32
Ataxia and pancytopenia caused by a mutation in TINF2
Tsangaris, E., Adams, S., Yoon, G., Chitayat, D. A., Lansdorp, P. M., Dokal, I. S., & Dror, Y. (2008) · Human Genetics · doi:10.1007/s00439-008-0576-7 · Cited by 32
Self-citationInherited bone marrow failure syndromes in 2012
Sakaguchi, H., Nakanishi, K., & Kojima, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1249-9 · Cited by 32
Akt regulates TPP 1 homodimerization and telomere protection
Han, X., Liu, D., Zhang, Y., Li, Y., Lu, W., Chen, J., & Songyang, Z. (2013) · Aging Cell · doi:10.1111/acel.12137 · Cited by 32
Dyskerin, telomerase and the DNA damage response
Gu, B.-W., Bessler, M., & Mason, P. J. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7265 · Cited by 31
Telomere dysfunction in human diseases: the long and short of it!
Carroll, K. A., & Ly, H. (2009) · Europe PMC (PubMed Central) · Cited by 30
Role of angiotensin II in aging
Yi, W., Chen, F., Zhang, H., Tang, P., Yuan, M., Wen, J., Wang, S., & Cai, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1002138 · Cited by 31
Essential roles for Pot1b in HSC self-renewal and survival
Wang, Y., Shen, M., & Chang, S. S. (2011) · Blood · doi:10.1182/blood-2011-06-361527 · Cited by 28
Nelson, N. D., Dodson, L. M., Escudero, L., Sukumar, A. T., Williams, C. L., Mihalek, I., Baldan, A., Baird, D. M., & Bertuch, A. A. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00025-18 · Cited by 28
Tummala, H., Collopy, L. C., Walne, A. J., Ellison, A., Cardoso, S. R., Aksu, T., Yaralı, N., Aslan, D., Akata, R. F., Teo, J., et al. (2018) · Blood · doi:10.1182/blood-2018-03-837799 · Cited by 27
Means to the ends: The role of telomeres and telomere processing machinery in metastasis
Robinson, N. J., & Schiemann, W. P. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.005 · Cited by 28
Zeng, X., Thumati, N. R., Fleisig, H. B., Hukezalie, K. R., Savage, S. A., Giri, N., Alter, B. P., & Wong, J. M. Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr504 · Cited by 28
Self-citationGastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders
Himes, R., Chiou, E., Queliza, K., Shouval, D. S., Somech, R., Agarwal, S., Jajoo, K., Ziegler, D. S., Kratz, C. P., Huang, J. N., et al. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.09.038 · Cited by 28
Self-citationTIN2 Stability Is Regulated by the E3 Ligase Siah2
Bhanot, M., & Smith, S. H. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06227-11 · Cited by 27
Patel, M. M., Talcott, K. E., Kim, D. Y., Agarwal, S., & Mukai, S. (2017) · Ophthalmic Genetics · doi:10.1080/13816810.2016.1275019 · Cited by 27
Telomerase and telomere biology in hematological diseases: A new therapeutic target
Allegra, A., Innao, V., Penna, G., Gerace, D. G., Allegra, A. G., & Musolino, C. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.02.002 · Cited by 31
Gálvez, E. H., Vallespín, E., Arias‐Salgado, E. G., Sánchez-Valdepeñas, C., Gimenez, Y. A., Navarro, S., Rı́o, P., Bogliolo, M., Pujol, R. M., Peiró, M., et al. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000539 · Cited by 26
Defending the end zone: Studying the players involved in protecting chromosome ends
Chan, S., & Chang, S. S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.016 · Cited by 26
Richard, M. A., Lupo, P. J., Morton, L. M., Yasui, Y., Sapkota, Y., Arnold, M., Aubert, G., Neglia, J. P., Turcotte, L. M., Leisenring, W. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228887 · Cited by 28
Hoareau‐Aveilla, C., Henry, Y. A. L., & Leblanc, T. M. (2008) · médecine/sciences · doi:10.1051/medsci/2008244390 · Cited by 32
Metadata
- Authors
- Savage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P.
- Affiliations
- National Institutes of Health (US)
- University Hospital of Bern (CH)
- National Cancer Institute (US)
- Corresponding author
- Savage, Sharon A.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 82
- Issue
- 2
- Pages
- 501-509
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC2427222
- OpenAlex
- W2033942199
- Cited by
- 414
- References
- 46
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 16 · 2023: 15 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 29 · 2017: 17 · 2016: 17 · 2015: 21 · 2014: 27 · 2013: 29 · 2012: 25
- FWCI
- 28.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (N02 CP011019)
- National Institute of Allergy and Infectious Diseases (AI 29524, R21AI029524, R01AI029524)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- TIN2, dyskeratosis congenita, shelterin complex, telomere protection, bone marrow failure, autosomal dominant inheritance, germline mutations, telomere biology
- MeSH terms
- Adolescent, Adult, Base Sequence, Child, Child, Preschool, Chromosome Mapping, Chromosomes, Human, Pair 14, Humans, Molecular Sequence Data, Mutation, Pedigree, Telomere, Sequence Analysis, DNA, Dyskeratosis Congenita, Telomere-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review